Clinical Trials Directory

Trials / Unknown

UnknownNCT01699477

Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain

MR-Guided Functional Ultrasound-Neurosurgery

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to asses the efficacy and the clinical safety of the transcranial magnetic resonance guided high intensity focused ultrasound system ExAblate 4000, InSightec Ltd. for functional neurosurgery. The treatments to be conducted in this study are non-invasive, i.e. without opening the skull, and will create micro-thalamotomies in specific target areas such as thalamus, subthalamus and pallidum. The data obtained in this study will be used to evaluate the basic safety aspects of this new treatment technology and will serve as a basis for the clinical introduction of MR-guided ultrasound-neurosurgery.

Conditions

Interventions

TypeNameDescription
DEVICEExAblate 4000 focused ultrasound brain interventionNon-invasive brain intervention using MR-guided focused ultrasound

Timeline

Start date
2008-08-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-10-03
Last updated
2012-10-03

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01699477. Inclusion in this directory is not an endorsement.